Genentech relaunched with independence intact.
Glaser
V
V
D000911:Antibodies, Monoclonal / Q000191:economics; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D001709:Biotechnology / Q000191:economics*; D017277:Drug Approval; D004345:Drug Industry / Q000191:economics; D019382:Human Growth Hormone; D006801:Humans; D007449:Investments; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D000069283:Rituximab; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D019382:Human Growth Hormone; D000069283:Rituximab; D000068878:Trastuzumab